Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis

K. A. Rahn, C. C. Watkins, J. Alt, R. Rais, M. Stathis, I. Grishkan, C. M. Crainiceau, M. G. Pomper, C. Rojas, M. V. Pletnikov, P. A. Calabresi, J. Brandt, P. B. Barker, B. S. Slusher, A. I. Kaplin
  • Proceedings of the National Academy of Sciences, November 2012, Proceedings of the National Academy of Sciences
  • DOI: 10.1073/pnas.1209934109

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Jason Brandt

In partnership with: